Skip to main content
. 2017 Aug 27;8(53):90852–90867. doi: 10.18632/oncotarget.20310

Figure 5. Busulfan plasma exposure and clinical outcomes of HSCT.

Figure 5

Incidences of event-free survival (EFS), overall survival (OS), and treatment related toxicity (TRT) plotted against 3 groups based on first dose steady state concentration (Css) i.e. <600, 600-900 and > 900 ng/mL in all patients (n = 138). Total number of patients in each group (number of patients with events) are depicted on all plots. P values are shown on the plots.